Published in Medical Device Business Week, March 21st, 2007
"The aim of this study was to evaluate the clinical value of the OptiVol alert and its prediction for decompensated HF....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.